Clinical trial

Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT…

NCT00213746 · University Hospital, Rouen, Other · Completed

Key facts

NCT number NCT00213746
Title Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)
Official title Prediction of Left Ventricular Function Changes Using Low Dose Dobutamine Gated SPECT in Patients Referred for Viability Assessment: The DOGS (DObutamine Gated Spect)Study.
Lead sponsor University Hospital, Rouen, Other
Collaborators Bristol-Myers Squibb Industry GE Healthcare Fédération Française de Cardiologie Société Française de Cardiologie Société Française de Médecine Nucléaire
Status Completed
Study type Observational
Conditions Coronary Arteriosclerosis, Heart Failure, Congestive, Myocardial Infarction, Myocardial Ischemia, Myocardial Stunning
Enrollment 75
Start date Oct 1, 2003
Completion Dec 1, 2005
First posted Sep 21, 2005
Last update posted Jun 18, 2013
Countries Belgium, France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies